Innate Pharma SA (IPHA)
1.48
-0.04
(-2.63%)
USD |
NASDAQ |
Oct 08, 16:00
1.49
+0.01
(+0.68%)
Pre-Market: 08:28
Innate Pharma Market Cap : 138.98M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 138.98M |
| October 07, 2026 | 142.73M |
| October 06, 2026 | 149.31M |
| October 05, 2026 | 148.37M |
| October 02, 2026 | 146.49M |
| October 01, 2026 | 149.31M |
| September 30, 2026 | 153.06M |
| September 29, 2026 | 150.25M |
| September 28, 2026 | 159.64M |
| September 25, 2026 | 159.64M |
| September 24, 2026 | 159.64M |
| September 23, 2026 | 165.27M |
| September 22, 2026 | 169.03M |
| September 21, 2026 | 174.66M |
| September 18, 2026 | 178.42M |
| September 17, 2026 | 179.36M |
| September 16, 2026 | 188.75M |
| September 15, 2026 | 174.66M |
| September 14, 2026 | 173.72M |
| September 11, 2026 | 175.22M |
| September 10, 2026 | 176.16M |
| September 09, 2026 | 182.72M |
| September 08, 2026 | 192.09M |
| September 04, 2026 | 194.90M |
| September 03, 2026 | 197.71M |
| Date | Value |
|---|---|
| September 02, 2026 | 203.33M |
| September 01, 2026 | 198.65M |
| August 31, 2026 | 203.33M |
| August 28, 2026 | 208.02M |
| August 27, 2026 | 208.95M |
| August 26, 2026 | 202.39M |
| August 25, 2026 | 212.70M |
| August 24, 2026 | 206.61M |
| August 21, 2026 | 211.76M |
| August 20, 2026 | 195.83M |
| August 19, 2026 | 198.65M |
| August 18, 2026 | 193.96M |
| August 17, 2026 | 211.76M |
| August 14, 2026 | 204.27M |
| August 13, 2026 | 237.53M |
| August 12, 2026 | 231.44M |
| August 11, 2026 | 201.46M |
| August 10, 2026 | 208.02M |
| August 07, 2026 | 162.10M |
| August 06, 2026 | 167.26M |
| August 05, 2026 | 165.85M |
| August 04, 2026 | 167.26M |
| August 03, 2026 | 161.17M |
| July 31, 2026 | 163.98M |
| July 30, 2026 | 163.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nicox SA | 26.44M |
| DBV Technologies SA | 565.20M |
| Cellectis SA | 125.87M |
| Genfit SA | 787.99M |
| Inventiva SA | 784.45M |
Market Cap Related Metrics
| PS Ratio | 28.12 |
| PEG Ratio | -0.0845 |
| Price | 1.48 |
| Earnings Yield | -39.89% |
| PEGY Ratio | -0.0845 |